Address
Hatteras Venture Partners III
280 S Mangum St
Suite 510
Durham, NC 27701
United States
Phone
Website
VCID: 110885
Profile
Corporate information
Also known as
HVP III
Registration country
Also known as
HVP III
Registration country
Investment activity status
Active investor
Fund terms
Fund manager
Vintage
2007
Country from which managed
United States
Fund type
Funding
Funding rounds
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
TetraLogic Pharmaceuticals A leader in the discovery and development of small molecule drugs called Smac mimetics for the treatment of cancers. |
United States | 1 Aug 2010 | Series C |
|
|
|
Viamet Pharmaceuticals Inc |
United States | 1 Jul 2009 | Series B |
|
|
|
GeneCentric Diagnostics Focused on the development and commercialization of novel molecular diagnostic assays |
United States | N/A |
||
|
|
HistoSonics Inc Venture-backed medical device company developing a non-invasive robotic platform and novel beam therapy. |
United States | N/A Active |
||
|
|
Pathfinder Therapeutics Inc A medical device company dedicated to increasing the number and effectiveness of surgeries on abdominal and other soft tissue organs. |
United States | N/A |
||
|
|
ArtusLabs Inc |
United States | N/A Active |
||
|
|
PhaseBio Pharmaceuticals Inc |
United States | N/A |
||
|
|
Clearside Biomedical Inc Ophthalmic company specializing in the research, development and commercialization of therapeutic products. |
United States | N/A |
||
|
|
SpineAlign Medical Inc Designs, develops, and commercializes medical devices for the treatment of spine disorders. |
United States | N/A |
||
|
|
Device Innovation Group |
United States | N/A |
||
|
|
Clinipace Worldwide Digital clinical research organization. |
United States | N/A |
||
|
|
Embrella Cardiovascular Inc |
United States | N/A |